Verdict: Mixed

Key finding: There is no Teradyne-specific news. TER is down ~7% with the whole chip-equipment group after Lam Research guided the December quarter only in line, citing component shortages and a meaningfully lower China share. TER's own numbers are the best in its test group (revenue +104% YoY, 32.9% op margin), and it reports in 3 sessions (10/27 after the close).

Scorecard

Ticker Rev last Q ($M) Rev YoY last Q Rev YoY prior Q Gross margin (last Q, trend) Op margin EPS last Q vs yr ago P/S Mkt cap 1-mo price %
TER 1,329 +103.9% +87.0% 59.8% (down from 60.9%) 32.9% 2.38 vs 0.49 11.1 $49.3B -9.4%
FORM 258 +31.9% +32.0% 50.7% (up from 47.9%) 22.4% 0.70 vs 0.12 8.8 $7.9B -6.0%
COHU 149 +38.4% +29.3% 45.4% (up from 40.5%) 0.2% -0.00 vs -0.36 4.5 $2.4B -8.8%
AEHR 20 +40.2% -43.7% 40.6% (up from 32.7%) -5.0% 0.05 vs -0.10 37.9 $1.9B -34.1%

TER is the quality leader of the test group: revenue growth (+104%) is 3x the peers and op margin (32.9%) is the highest, with growth still accelerating (+87% to +104%). It is not the cheapest (P/S 11.1 vs FORM 8.8), and gross margin slipped 1.1 pts last quarter.

Move

Catalyst

Sector

Risks

Judgement

Mixed. The drop is sympathy, not Teradyne news, and TER's own numbers are the strongest in the test group. But the sector reason is real (Lam's shortages and China), and TER's own answer comes in 3 sessions. On the facts available today, the business case is intact; whether this is an overreaction depends on the 10/27 report.

Sources